ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $329,000 | -46.4% | 22,650 | -33.6% | 0.00% | -100.0% |
| Q3 2021 | $614,000 | +96.2% | 34,106 | +91.3% | 0.00% | – |
| Q2 2021 | $313,000 | +53.4% | 17,824 | +120.6% | 0.00% | – |
| Q1 2021 | $204,000 | +1357.1% | 8,078 | -36.2% | 0.00% | – |
| Q1 2020 | $14,000 | +100.0% | 12,662 | +83.2% | 0.00% | – |
| Q3 2019 | $7,000 | -98.9% | 6,910 | -93.2% | 0.00% | -100.0% |
| Q1 2019 | $612,000 | +14.6% | 102,251 | +41.5% | 0.00% | 0.0% |
| Q4 2018 | $534,000 | -50.0% | 72,281 | -1.8% | 0.00% | -50.0% |
| Q3 2018 | $1,069,000 | -30.8% | 73,631 | -4.8% | 0.00% | -33.3% |
| Q2 2018 | $1,545,000 | +8.2% | 77,371 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $1,428,000 | -21.2% | 81,491 | +10.9% | 0.00% | -25.0% |
| Q4 2017 | $1,813,000 | +18.7% | 73,501 | +24.1% | 0.00% | +33.3% |
| Q3 2017 | $1,528,000 | +37.4% | 59,211 | +44.3% | 0.00% | 0.0% |
| Q2 2017 | $1,112,000 | -10.0% | 41,021 | -1.1% | 0.00% | 0.0% |
| Q1 2017 | $1,236,000 | -18.9% | 41,461 | -26.2% | 0.00% | -25.0% |
| Q4 2016 | $1,524,000 | – | 56,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |